Arena Pharmaceuticals Inc (ARNA)

Add to Watchlists
Create an Alert
49.15 -0.73  -1.46% NASDAQ Feb 21, 20:00 Delayed 2m USD
View Full Chart
ARNA Price Chart
View All Events

ARNA Events

Date Type Description
03/14/2019 08:30 EDT Misc Arena Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
03/14/2019 Earnings Arena Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release
11/07/2018 16:30 EST Misc Arena Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018
11/07/2018 Earnings Arena Pharmaceuticals Inc Third Quarter Earnings in 2018 Release
08/06/2018 16:30 EDT Misc Arena Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018
08/06/2018 Earnings Arena Pharmaceuticals Inc Second Quarter Earnings Results in 2018
06/13/2018 Misc Arena Pharmaceuticals Inc Annual General Meeting in 2017
05/08/2018 16:30 EDT Misc Arena Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018
05/08/2018 Earnings Arena Pharmaceuticals Inc First Quarter Earnings Results in 2018
03/14/2018 Earnings Arena Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017
View All Performance Charts

ARNA Total Returns Comparison

Advertisement

ARNA One Page Reports

Edit

Profile

  • URL: http://www.arenapharm.com
  • Investor Relations URL: http://invest.arenapharm.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Mar. 14, 2019
  • Last Earnings Release: Nov. 07, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company’s pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

ARNA Comparables

Edit

ARNA Excel Add-In Codes

  • Name: =YCI("ARNA","name")
  • Description: =YCI("ARNA","description")
  • Sector: =YCI("ARNA","sector")
  • Industry: =YCI("ARNA","industry")
  • Est. Current Fiscal Year End: =YCI("ARNA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.